ClinicalTrials.gg

How we know

Every link on this study, and who decided it

The study on the left, the conditions and drugs this site links it to, and on each link the judgments that made or checked it, by day and by judge. The top row is the record itself: each new version seen since tracking began. Dashed lines are links the registry record does not make itself. Select a link to see everything judged on it, or a mark for one decision with its reason and evidence.

Why Bevacizumab is on this study

  • The record lists it as a treatment.
  • A model not recorded judged it tested: part of what the study tests. Nov 1, 2026, 4:45 AM UTC
  • The role rule says the same.
  • So Bevacizumab's page lists this study under “Testing it”.
5 links0 made here, not in the record9 judgments2 judges (the rules as one: Rule based)21 record changes seen
Model not recordedRule basedRecord updated on ClinicalTrials.gov
Sep 28Oct 5Oct 12Oct 19Oct 26Nov 2Nov 9Nov 16Nov 23TodayNCT07198074Testing the Addition of anAntiangiogenic Drug(Bevacizumab) toChemotherapy (Carboplatinand Paclitaxel) CombinedWith Immunotherapy(Pembrolizumab) for pMMR,National Cancer Institute (NCIPhase 3 · recruitingRECORDThe record itselfVersions seen nightly since Sep 25, 2…›Sep 25 · ClinicalTrials.gov record · Version of 2026-09-25Sep 29 · ClinicalTrials.gov record · Version of 2026-09-29Sep 30 · ClinicalTrials.gov record · Version of 2026-09-30Oct 1 · ClinicalTrials.gov record · Version of 2026-10-01Oct 2 · ClinicalTrials.gov record · Version of 2026-10-02Oct 5 · ClinicalTrials.gov record · Version of 2026-10-05Oct 6 · ClinicalTrials.gov record · Version of 2026-10-06Oct 7 · ClinicalTrials.gov record · Version of 2026-10-07Oct 9 · ClinicalTrials.gov record · Version of 2026-10-09Oct 14 · ClinicalTrials.gov record · Version of 2026-10-14Oct 19 · ClinicalTrials.gov record · Version of 2026-10-19Oct 21 · ClinicalTrials.gov record · Version of 2026-10-21Oct 22 · ClinicalTrials.gov record · Version of 2026-10-22Oct 23 · ClinicalTrials.gov record · Version of 2026-10-23Nov 2 · ClinicalTrials.gov record · Version of 2026-11-02Nov 3 · ClinicalTrials.gov record · Version of 2026-11-03Nov 4 · ClinicalTrials.gov record · Version of 2026-11-04Nov 5 · ClinicalTrials.gov record · Version of 2026-11-05Nov 6 · ClinicalTrials.gov record · Version of 2026-11-06Nov 18 · ClinicalTrials.gov record · Version of 2026-11-18Nov 20 · ClinicalTrials.gov record · Version of 2026-11-20Version of 2026-11-20CONDITIONSEndometrial NeoplasmsThe registry's MeSH filing›As of now · Rule based · Main conditionMain conditionDRUGSBevacizumabIntervention entry›Nov 1 · A model not recorded · TestedNov 18 · Rule based · TestedTestedCarboplatinIntervention entry›Nov 1 · A model not recorded · BackgroundNov 18 · Rule based · BackgroundBackgroundPaclitaxelIntervention entry›Nov 1 · A model not recorded · BackgroundNov 18 · Rule based · BackgroundBackgroundPembrolizumabIntervention entry›Nov 1 · A model not recorded · TestedNov 18 · Rule based · TestedTested

Times are in your time zone; a day marked “day only” kept no time. The graph scrolls sideways on a narrow screen; every mark is also in the list below.

All judgments on this study

WhenLinkJudgeDecisionState
21 versions of the record seen on ClinicalTrials.gov, Sep 25–Nov 20 · changes seen, not judgments
Nov 1BevacizumabA model not recordedTestedCurrent
Nov 1CarboplatinA model not recordedBackgroundCurrent
Nov 1PaclitaxelA model not recordedBackgroundCurrent
Nov 1PembrolizumabA model not recordedTestedCurrent
Nov 18BevacizumabRule based · role ruleTestedAgrees
Nov 18CarboplatinRule based · role ruleBackgroundAgrees
Nov 18PaclitaxelRule based · role ruleBackgroundAgrees
Nov 18PembrolizumabRule based · role ruleTestedAgrees
As of nowEndometrial NeoplasmsRule based · main-condition ruleMain conditionCurrent

The rules, in plain words

“Rule based” means one of these decided, not a model or a person. Each runs every night over every study.

Which drugs a study tests

Reads each treatment the study lists and the arms it is in. A drug only in the experimental arm is tested. A drug in every arm while something else changes between the arms is given beside it. A drug only in the control arm is the comparator. Placebo, procedures and usual care are known by name.

Where the whole record has been read, that reading's answer replaces the rule's.

What a study is mainly about

Starts from the first condition ClinicalTrials.gov files the study under. It moves to a narrower one only when the study's own title or listed conditions name it, and sets aside terms the registry often files by mistake. A study open to many cancers is not placed under one of them unless its title names it.

Checked against studies judged one by one; the study page says when it differs from the registry.